Viewing Study NCT01511432


Ignite Creation Date: 2025-12-24 @ 9:47 PM
Ignite Modification Date: 2025-12-25 @ 7:26 PM
Study NCT ID: NCT01511432
Status: COMPLETED
Last Update Posted: 2012-07-04
First Post: 2012-01-09
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: A Study to Assess the Relative Bioavailability Three New Formulations of Telaprevir in Healthy Subjects
Sponsor: Vertex Pharmaceuticals Incorporated
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module